The effects of TPA023, a GABAAα2,3 subtype-selective partial agonist, on essential tremor in comparison to alcohol.

Autor: de Haas, SL, Zoethout, RWM, Van Dyck, K, De Smet, M, Rosen, LB, Murphy, MG, Gottesdiener, KM, Schoemaker, RC, Cohen, AF, van Gerven, JMA

Publikováno v: Journal of Psychopharmacology; Feb2012, Vol. 26 Issue 2, p282-291, 10p

The effects of the glycine reuptake inhibitor R213129 on the central nervous system and on scopolamine-induced impairments in psychomotor and cognitive function in healthy subjects.

Autor: Liem-Moolenaar, M, Zoethout, RWM, de Boer, P, Schmidt, M, de Kam, ML, Cohen, AF, Franson, KL, van Gerven, JMA

Publikováno v: Journal of Psychopharmacology; Nov2010, Vol. 24 Issue 11, p1671-1679, 9p

Correction to: Quality of Life Analysis of Patients Treated with Percutaneous Hepatic Perfusion for Uveal Melanoma Liver Metastases.

Autor: Tong TML; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Fiocco M; Mathematical Institute, Leiden University, Leiden, The Netherlands.; Medical Statistics Section, Department of Biomedical Data Science, Leiden University Medical Center, Leiden, The Netherlands., van Duijn-de Vreugd JJ; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Lutjeboer J; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Tijl FGJ; Department of Extra Corporal Circulation, Leiden University Medical Center, Leiden, The Netherlands., Sitsen ME; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands., Zoethout RWM; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands., Martini CH; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands., Vahrmeijer AL; Department of Surgery, Leiden University Medical Center, Leiden, The Netherlands., van der Meer RW; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., van Rijswijk CSP; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., van Erkel AR; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Leiden, The Netherlands., Burgmans MC; Interventional Radiology Research (IR2) Group, Department of Radiology, C2-S, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands. M.C.Burgmans@lumc.nl.

Publikováno v: Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2024 Jun; Vol. 47 (6), pp. 856.

Combining Melphalan Percutaneous Hepatic Perfusion with Ipilimumab Plus Nivolumab in Advanced Uveal Melanoma: First Safety and Efficacy Data from the Phase Ib Part of the Chopin Trial.

Autor: Tong TML; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands.; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Burgmans MC; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Speetjens FM; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., van Erkel AR; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., van der Meer RW; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., van Rijswijk CSP; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Jonker-Bos MA; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Roozen CFM; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Sporrel-Blokland M; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands., Lutjeboer J; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., van Persijn van Meerten EL; Department of Radiology, Leiden University Medical Center, Leiden, The Netherlands., Martini CH; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands., Zoethout RWM; Department of Anesthesiology, Leiden University Medical Center, Leiden, The Netherlands., Tijl FGJ; Department of Extra Corporal Circulation, Leiden University Medical Center, Leiden, The Netherlands., Blank CU; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands.; Department of Medical Oncology, The Netherlands Cancer Institute - Antoni Van Leeuwenhoek Hospital, Amsterdam, The Netherlands., Kapiteijn E; Department of Medical Oncology, Leiden University Medical Center, Postal Zone C7-P, Albinusdreef 2, 2333ZA, Leiden, The Netherlands. h.w.kapiteijn@lumc.nl.

Publikováno v: Cardiovascular and interventional radiology [Cardiovasc Intervent Radiol] 2023 Mar; Vol. 46 (3), pp. 350-359. Date of Electronic Publication: 2023 Jan 09.